Compare Edwards Lifesciences Corporation Common Stock (EW) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Kraft Heinz Co — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Kraft Heinz Co trades at $22.51 (market cap $26.06B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Kraft Heinz Co pays a 7.28% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | KHC | |
|---|---|---|
Market Cap | $49.44B | $26.06B |
Volume | 3,508,027 | 15,326,651 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $27.62 |
52-Week Low | $72.65 | $21.21 |
Enterprise Value | $45.90B | $42.38B |
Typical Hold Time | — | 129 Days |
Dividend Yield | — | 7.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kraft Heinz (KHC) trades at $22.48, up 2.04% today, with a bearish technical signal but recent earnings beats. The stock shows a low P/E of 13.04 and P/B of 0.72, yet profitability is weak with a -13.64% net margin. Cash flow improved to $1.46B in 2025, but a $5.85B net loss and high debt of $19.22B pose challenges. News highlights dividend stability and brand revitalization efforts, such as new Philadelphia cream cheese flavors.
Outlook remains cautious; the stock offers value with a dividend yield near 6%, but turnaround success is critical. Risks include sustained volume declines and debt servicing. Analysts are mixed with a $23.78 consensus target, suggesting limited upside. Institutional interest exists, but weak fundamentals warrant careful monitoring for recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
